Incyte Corp (MIL:1INCY)
€ 66.84 0 (0%) Market Cap: 13.69 Bil Enterprise Value: 12.09 Bil PE Ratio: 541.07 PB Ratio: 4.61 GF Score: 70/100

Incyte Corp to Discuss the Key Data Presentations at ASH Transcript

Dec 11, 2023 / 08:00PM GMT

Dec 11, 2023 / 08:00PM GMT
Presentations at ASH
Dec 11, 2023 / 08:00PM GMT

=====================
Corporate Participants
=====================
* Pablo J. Cagnoni
Incyte Corporation - President and Head of Research & Development
* Patrick Mayes
Incyte Corporation - VP of Biotherapeutic Research
* Peter Langmuir

=====================
Conference Call Participants
=====================
* Conor Thomas MacKay
BMO Capital Markets Equity Research - Research Associate
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Eva Xia Privitera
TD Cowen, Research Division - Associate
* Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
* Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst
* Leonid Timashev
RBC Capital Markets, Research Division - Biotechnology Analyst
* Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst &

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot